This preprint is under consideration at Malaria Journal. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Case study
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Thailand’s National Malaria Elimination Strategy 2017–2026 introduced the 1-3-7 strategy as a robust surveillance and response approach for elimination that would prioritize timely, evidence-based action. Under this strategy, cases are reported within 1 day, cases are investigated within 3 days, and foci are investigated and responded to within 7 days, building on Thailand’s long history of conducting case investigation since the 1980s. However, the hallmark of the 1-3-7 strategy is timeliness, with strict deadlines for reporting and response to accelerate elimination. This paper outlines Thailand’s experience adapting and implementing the 1-3-7 strategy, including success factors such as a cross-sectoral Steering Committee, participation in a collaborative regional partnership, and flexible local budgets. The program continues to evolve to ensure prompt and high-quality case management, capacity maintenance, and adequate supply of lifesaving commodities based on surveillance data. Results from implementation suggest the 1-3-7 strategy has contributed to Thailand’s decline in malaria burden; this experience may be useful for other countries aiming to eliminate malaria.
Keywords
Elimination, surveillance, 1-3-7 strategy
Figure 1
Figure 2
Figure 3
Figure 4
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Review
Version (no preprint)
Posted 18 Apr, 2021
Editor assigned
On 17 Apr, 2021
Submission checks complete
On 17 Apr, 2021
Editor invited
On 17 Apr, 2021
This version was not preprinted
Version 1
Posted 12 Mar, 2021
No community comments so far
Editorial decision: Minor Revision
On 05 Apr, 2021
Reviewer #2 agreed
On 30 Mar, 2021
Review #2 received
Received 30 Mar, 2021
Reviews received
Received 30 Mar, 2021
Review #1 received
Received 30 Mar, 2021
Reviewer #1 agreed
On 21 Mar, 2021
Reviewers invited
Invitations sent on 19 Mar, 2021
First submitted
On 02 Mar, 2021
Editor assigned
On 02 Mar, 2021
Submission checks complete
On 02 Mar, 2021
Editor invited
On 02 Mar, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Infectious Diseases
Learn more about our company.
This preprint is under consideration at Malaria Journal. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Case study
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Review
Version (no preprint)
Posted 18 Apr, 2021
Editor assigned
On 17 Apr, 2021
Submission checks complete
On 17 Apr, 2021
Editor invited
On 17 Apr, 2021
This version was not preprinted
Version 1
Posted 12 Mar, 2021
No community comments so far
Editorial decision: Minor Revision
On 05 Apr, 2021
Reviewer #2 agreed
On 30 Mar, 2021
Review #2 received
Received 30 Mar, 2021
Reviews received
Received 30 Mar, 2021
Review #1 received
Received 30 Mar, 2021
Reviewer #1 agreed
On 21 Mar, 2021
Reviewers invited
Invitations sent on 19 Mar, 2021
First submitted
On 02 Mar, 2021
Editor assigned
On 02 Mar, 2021
Submission checks complete
On 02 Mar, 2021
Editor invited
On 02 Mar, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Infectious Diseases
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Thailand’s National Malaria Elimination Strategy 2017–2026 introduced the 1-3-7 strategy as a robust surveillance and response approach for elimination that would prioritize timely, evidence-based action. Under this strategy, cases are reported within 1 day, cases are investigated within 3 days, and foci are investigated and responded to within 7 days, building on Thailand’s long history of conducting case investigation since the 1980s. However, the hallmark of the 1-3-7 strategy is timeliness, with strict deadlines for reporting and response to accelerate elimination. This paper outlines Thailand’s experience adapting and implementing the 1-3-7 strategy, including success factors such as a cross-sectoral Steering Committee, participation in a collaborative regional partnership, and flexible local budgets. The program continues to evolve to ensure prompt and high-quality case management, capacity maintenance, and adequate supply of lifesaving commodities based on surveillance data. Results from implementation suggest the 1-3-7 strategy has contributed to Thailand’s decline in malaria burden; this experience may be useful for other countries aiming to eliminate malaria.
Figure 1
Figure 2
Figure 3
Figure 4
Loading...